Onconetix, Inc. Income Taxes Paid
Onconetix, Inc. (ONCO) reported Income Taxes Paid of $188.31 thousand for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-13.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaid · last filed 2025-11-13
- Onconetix, Inc. income taxes paid for the quarter ending 2025-09-30 was $3.77K, a 75.30% decline year-over-year.
- Onconetix, Inc. income taxes paid for the quarter ending 2025-06-30 was $163.38K.
- Onconetix, Inc. income taxes paid for the quarter ending 2025-03-31 was $21.16K, a 380.41% increase year-over-year.
- Onconetix, Inc. income taxes paid for the quarter ending 2024-12-31 was $359.75K.
- Onconetix, Inc. income taxes paid for fiscal 2024 was $379.41K.
| Period end | Income Taxes Paid 3 month | Income Taxes Paid 6 month | Income Taxes Paid 9 month | Income Taxes Paid 12 month |
|---|---|---|---|---|
| 2025-09-30 | $3.77K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $167.15K derived: sum of 2 quarters · filed 2025-11-13 | $188.31K 10-Q · filed 2025-11-13 | $548.06K derived: sum of 4 quarters · filed 2025-11-13 |
| 2025-06-30 | $163.38K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $184.55K 10-Q · filed 2025-08-14 | $544.30K derived: sum of 3 quarters · filed 2025-08-14 | $559.55K derived: sum of 4 quarters · filed 2025-11-13 |
| 2025-03-31 | $21.16K 10-Q · filed 2025-06-12 | $380.91K derived: sum of 2 quarters · filed 2025-06-12 | $396.17K derived: sum of 3 quarters · filed 2025-11-13 | $396.17K derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-12-31 | $359.75K derived: 10-K 12 month − 10-Q 9 month · filed 2025-06-02 | $375.00K derived: sum of 2 quarters · filed 2025-11-13 | $375.00K derived: sum of 3 quarters · filed 2025-11-13 | $379.41K 10-K · filed 2025-06-02 |
| 2024-09-30 | $15.25K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $15.25K derived: sum of 2 quarters · filed 2025-11-13 | $19.66K 10-Q · filed 2025-11-13 | |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $4.41K 10-Q · filed 2025-08-14 | ||
| 2024-03-31 | $4.41K 10-Q · filed 2025-06-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |